Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.

Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Th├ębaud B, Trapnell BC, Weiss DJ, Yuan JX, Blaisdell CJ.

Am J Respir Crit Care Med. 2013 Aug 1;188(3):370-5. doi: 10.1164/rccm.201303-0522WS. Review.

2.

What is the greatest regulatory challenge in the translation of biomaterials to the clinic?

Prestwich GD, Bhatia S, Breuer CK, Dahl SL, Mason C, McFarland R, McQuillan DJ, Sackner-Bernstein J, Schox J, Tente WE, Trounson A.

Sci Transl Med. 2012 Nov 14;4(160):160cm14. doi: 10.1126/scitranslmed.3004915.

PMID:
23152323
3.

Readily available tissue-engineered vascular grafts.

Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE.

Sci Transl Med. 2011 Feb 2;3(68):68ra9. doi: 10.1126/scitranslmed.3001426.

4.

Lack of impact of rapid identification of rotavirus-infected patients on nosocomial rotavirus infections.

Dennehy PH, Tente WE, Fisher DJ, Veloudis BA, Peter G.

Pediatr Infect Dis J. 1989 May;8(5):290-6. Review.

PMID:
2657618
5.

Comparison of nine commercial immunoassays for the detection of rotavirus in fecal specimens.

Dennehy PH, Gauntlett DR, Tente WE.

J Clin Microbiol. 1988 Sep;26(9):1630-4.

Supplemental Content

Support Center